COVID-19 collaborative program reduces mortality in long-term care facilities

A collaborative program developed at UVA Health to work with local long-term care facilities control COVID-19 is saving lives and offers a model for communities across the country, a new scientific paper reports.

The program has helped prevent COVID-19 infections and reduced mortality when outbreaks occur, its creators say. Of the first two facility outbreaks that the team has worked with, there were lower mortality rates than seen in previous outbreaks - 12% and 19%. That's compared with a 28% mortality rate reported at a long-term care facility in Washington state.

Developing this program has been a wonderful collaboration amongst many sites of care and types of care provider. We call the program GERI-PaL - meaning Geriatric Engagement and Resource Integration for Post-Acute and Long-Term Care Facilities - and it has been a great opportunity to bring together hospital and community-based resources to assist our local facilities in preventing and responding to COVID-19 outbreaks."

UVA Health geriatrician Laurie R. Archbald-Pannone, MD, MPH, the program's lead physician

A practical approach to controlling COVID-19

Archbald-Pannone and her colleagues describe the program as a "practical approach" to controlling COVID-19 in long-term-care facilities. Such facilities have been hard-hit by the pandemic because of the vulnerable health of many residents and the intensive nature of the care provided.

In their new paper, the UVA team highlights five key components of the program:

Infection advisory consultations: UVA Health infection-control experts worked hand-in-hand with the long-term care facilities to develop effective infection-control policies and address issues such as staffing needs and access to personal-protective equipment (PPE).

Project ECHO: A geriatrician, pulmonologist, nurse practitioner, clinical nurse leader and nurse educator were all made available using a model based on Project ECHO, a program that offers training and support for health professionals. The group met virtually with their colleagues at the nursing facilities to provide the latest COVID-19 information, testing and treatment guidance.

Telemedicine consultations: UVA Health pulmonary/critical-care and geriatric and palliative medicine experts provided consultations via telemedicine on testing, monitoring and treating facility residents for COVID-19. The team also facilitated transfers to the hospital, when needed, and transfers back to the nursing facilities when the patients had recovered sufficiently. The team also worked closely with the primary-care physicians to assist in decision-making and treatment of these patients.

Nursing liaisons: A nursing liaison offered concierge-style service for each facility, helping to keep lines of communication open and ensure any needs were met.

Resident social remote connections: Volunteer medical students spoke with residents by telephone to combat social isolation and keep their spirits up.

This program has really been a team effort and highlights the dedication of colleagues across the healthcare continuum - physicians, nurses, administrators, technology experts, local health officials and more - all coming together to support work with our local facilities amidst the challenges of COVID-19. We have all faced many challenges over the past few months. It's been an honor to help support our local facilities and their dedicated staff members in the care of these vulnerable patients. Many of the systems we've put in place and lessons we have learned will be value to improve care beyond even COVID-19."

Laurie R. Archbald-Pannone, MD

Results described

The UVA Health team members have described their experiences in the Journal of the American Medical Directors Association. The team consisted of Archbald-Pannone, Drew Harris, Kimberly Albero, Rebecca Steele, Aaron Pannone and Justin Mutter.

Source:
Journal reference:

Archbald-Pannone, L.R., et al. (2020) Pragmatic Innovations in Post-Acute and Long-Term Care Medicine. Journal of the American Medical Directors Association. doi.org/10.1016/j.jamda.2020.05.044.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients